Virtu Financial LLC - AKARI THERAPEUTICS PLC ownership

AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 16 filers reported holding AKARI THERAPEUTICS PLC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of AKARI THERAPEUTICS PLC
ValueSharesWeighting
Q2 2023$3
-40.0%
16,437
+56.7%
0.00%
-100.0%
Q4 2022$5
-100.0%
10,491
-37.1%
0.00%0.0%
Q1 2022$20,000
-50.0%
16,676
-8.0%
0.00%
-80.0%
Q2 2020$40,000
-24.5%
18,129
-41.8%
0.01%
+25.0%
Q3 2019$53,000
+140.9%
31,124
+185.8%
0.00%
+300.0%
Q2 2019$22,000
-84.6%
10,892
-72.7%
0.00%
-87.5%
Q1 2019$143,000
+146.6%
39,864
+33.8%
0.01%
+166.7%
Q2 2018$58,00029,8000.00%
Other shareholders
AKARI THERAPEUTICS PLC shareholders Q4 2022
NameSharesValueWeighting ↓
VHCP Management II, LLC 369,490$3,144,0001.61%
Vivo Capital, LLC 527,842$4,492,0001.40%
VHCP Management, LLC 158,352$1,348,0001.33%
Foresite Capital Management III, LLC 197,072$1,677,0000.78%
Boxer Capital, LLC 139,899$1,191,0000.53%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,150,700$9,792,0000.46%
NEA Management Company, LLC 452,167$3,848,0000.17%
RA Capital Management 114,039$970,0000.10%
ACUTA CAPITAL PARTNERS, LLC 23,169$197,0000.07%
QVT Financial LP 263,921$1,833,0000.07%
View complete list of AKARI THERAPEUTICS PLC shareholders